RBV Capital
Overview
RBV Capital is a EU based dedicated life sciences venture fund. We invest into diversified assets in pharmaceuticals, biologics, digital healthcare products and medical devices answering to an unmet medical and market need and with a potential for global outreach.
Investments
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is RBV Capital based?
RBV Capital is headquartered in Zug, Zug, Switzerland.
When was RBV Capital founded?
RBV Capital was founded in 2014.
How many portfolio companies does RBV Capital have?
RBV Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in RBV Capital's portfolio?
Portfolio companies visible on Caplight include Immusoft, Grabr.
What was RBV Capital's most recent investment shown here?
RBV Capital's most recent investment in this portfolio sample was in Immusoft in 2020.
What sectors does RBV Capital focus on?
RBV Capital focuses on Healthcare & Life Sciences, Consumer & Commerce, FinTech.
What company stages does RBV Capital focus on?
RBV Capital typically invests at the Mid stage.
What is RBV Capital's AUM?
RBV Capital's assets under management are estimated between $50.0M and $100.0M.